Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth factor receptors are a class of transmembrane proteins that bind to specific growth factors, initiating signaling cascades crucial for cell differentiation, proliferation, development, and survival. These receptors typically have an extracellular ligand-binding domain, a transmembrane domain, and a cytoplasmic kinase domain. Activation often involves ligand-induced dimerization and autophosphorylation, triggering downstream pathways like JAK/STAT, MAPK/ERK, and PI3K/Akt. Dysregulation of growth factor receptors is closely linked with oncogenesis and targeted by modern cancer therapeutics.
Inhibition of receptor tyrosine kinase activity, blocking downstream signaling pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Factor Receptor (GFR).